Literature DB >> 3553402

Interstitial fluid lipoproteins.

C H Sloop, L Dory, P S Roheim.   

Abstract

While a wide variety of techniques has been used to collect samples of interstitial fluid, most of our detailed knowledge about the composition of interstitial fluid lipoproteins has come from lymph collection studies. The considerable variability of lymph data probably reflects the effect of variable metabolic modification and different capillary permeabilities on the lipoprotein composition of interstitial fluid. All density classes of plasma lipoproteins are present in lymph. In peripheral lymph, the lymph/plasma concentration ratios of lipoproteins vary from 0.03 for VLDL-sized particles to 0.2 for HDL. Lymph from more permeable vascular beds, such as lung and myocardium, contains proportionately more lipoproteins. Their lymph/plasma concentration ratios vary from 0.1 to 0.6. In general, lymph lipoproteins are more heterogeneous in size than their plasma counterparts. Lymph HDL and LDL contain larger and smaller particles than their plasma equivalents. Lymph lipoproteins have unusual shapes (square packing and discoidal), chemical compositions, and molecular charge, which suggest de novo formation and/or extensive peripheral modification. Lymph HDL and LDL are enriched in free cholesterol. Lymph HDL also has increased cholesterol/protein and phospholipid/protein (especially sphingomyelin) ratios (Sloop, C.H., L. Dory, and P.S. Roheim, unpublished observations). Lymph HDL apoprotein composition differs from that of plasma, with an increase in apoE and apoA-IV content relative to apoA-I. These discoidal HDL particles may be products of an initial stage of reverse cholesterol transport. We believe further study of their metabolic fate would give important information concerning the later stages of reverse cholesterol transport.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553402

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  43 in total

Review 1.  B cell follicles and antigen encounters of the third kind.

Authors:  Jason G Cyster
Journal:  Nat Immunol       Date:  2010-10-19       Impact factor: 25.606

2.  Proteoglycans can mediate renal lipoprotein retention.

Authors:  L R Tannock
Journal:  Diabetologia       Date:  2006-03-11       Impact factor: 10.122

3.  Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells.

Authors:  V M Atger; M de la Llera Moya; G W Stoudt; W V Rodrigueza; M C Phillips; G H Rothblat
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

4.  Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster.

Authors:  L A Woollett; D K Spady
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

Review 5.  Extrahepatic cell membrane lipid abnormalities and cellular dysfunction in liver disease.

Authors:  J S Owen
Journal:  Drugs       Date:  1990       Impact factor: 9.546

6.  Species-dependent chelation of (241)Am by DTPA Di-ethyl ester.

Authors:  James E Huckle; Matthew P Sadgrove; Russell J Mumper; Michael Jay
Journal:  Health Phys       Date:  2015-04       Impact factor: 1.316

Review 7.  Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient.

Authors:  Keisuke Yanagida; Timothy Hla
Journal:  Annu Rev Physiol       Date:  2016-10-21       Impact factor: 19.318

8.  Physiologically based pharmacokinetics of cyclosporine A: reevaluation of dose-nonlinear kinetics in rats.

Authors:  C Tanaka; R Kawai; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

9.  Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells.

Authors:  Su Duy Nguyen; Katariina Öörni; Miriam Lee-Rueckert; Tero Pihlajamaa; Jari Metso; Matti Jauhiainen; Petri T Kovanen
Journal:  J Lipid Res       Date:  2012-08-01       Impact factor: 5.922

10.  Recruitment and Collection of Dermal Interstitial Fluid Using a Microneedle Patch.

Authors:  Chandana Kolluru; Mikayla Williams; Jeremy Chae; Mark R Prausnitz
Journal:  Adv Healthc Mater       Date:  2019-01-04       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.